Doherty David T
Chief Financial Officer
Doherty David T has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 16, 2026.
On the most recent filing, Doherty David T is listed as Chief Financial Officer at Surgery Partners, Inc. Inside the rolling window, Doherty David T reported no open-market purchases and 2 open-market sales totaling $313K in SGRY. The largest disclosed transaction in the window is a sale of 14,574 SGRY shares on Mar 6, 2026, worth $202K.
Companies traded
Other insiders at SGRY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$313K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Doherty David T made?
Doherty David T has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Doherty David T trade?
Doherty David T has filed SEC Form 4 disclosures for 1 company, including SGRY.
When was Doherty David T's most recent SEC Form 4 filing?
Doherty David T's most recent SEC Form 4 filing on Tracefour is dated Mar 16, 2026.
What is Doherty David T's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Doherty David T is listed as Chief Financial Officer.
What is Doherty David T's total buy and sell value in the current window?
Inside the rolling retention window, Doherty David T bought $0 and sold $313K based on SEC Form 4 filings.
What was Doherty David T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,574 SGRY shares on 2026-03-06, worth $202K, per SEC Form 4 filings.